Thermo Fisher Scientific: Characterizing the Next Generation of Oligonucleotide Therapeutics

Oligonucleotides have been gaining considerable interest over the last few years with the advent of gene therapy and mRNA vaccines. In addition, the advances in lipid nanoparticles and viral vectors for the transport of oligonucleotide therapies has increased the popularity and need for analysis of oligonucleotide therapeutics. The Thermo Scientific team has over 20 years of innovations and publications around the separation of oligonucleotides. Join us as we review significant advances in this area.

Webinar key topics:

• The first example of a complete workflow for mRNA sequencing
• Sizes of linear chains, single or double stranded form, modifications to help with stability
• Synthetic oligonucleotides
• Gene therapy requirements, viral transport vectors

At the end, you will be able to ask questions with Thermo Scientific's top bioseparations expert.